secwatch / observer
8-K filed December 13, 2023, 6:59 PM ET ticker GNPX CIK 0001595248
other material confidence high sentiment neutral materiality 0.75

Genprex enters $25M at-the-market offering with H.C. Wainwright; ends JMP deal

Genprex, Inc.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Genprex, Inc. entered into At The Market Offering Agreement with H.C. Wainwright & Co., LLC valued at up to $25.0 million (effective 2023-12-13).

Action
entry
Agreement
atm program
Counterparty
H.C. Wainwright & Co., LLC
Value
up to $25.0 million
Effective
2023-12-13
Exact text from the filing
On December 13, 2023, Genprex, Inc. (the “Company”) entered into an At The Market Offering Agreement (the “Agreement”) with H.C. Wainwright & Co., LLC, serving as agent (the “Agent”) with respect to an at-the-market offering program under which the Company may offer and sell, from time to time at its sole discretion, shares of its common stock, par value $0.001 per share (the “Common Stock”), having an aggregate offering price of up to $25.0 million (the “Shares”) through the Agent (the “Offering”).
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Genprex, Inc. terminated Equity Distribution Agreement with JMP Securities LLC (effective 2023-12-12).

Action
termination
Agreement
atm program
Counterparty
JMP Securities LLC
Effective
2023-12-12
Exact text from the filing
On December 12, 2023, the Company provided notice of its termination of the Equity Distribution Agreement, dated as of November 18, 2022 (the “Equity Distribution Agreement”), by and between the Company and JMP Securities LLC.
View on SEC.gov

548 material agreements filed in the last 30 days. Browse all material agreements →

Genprex, Inc. filing history →

Source: SEC EDGAR
accession 0001437749-23-034341
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.